Posted by Michael Wonder on 04 Apr 2020
COVID-19: shipment of anti-depressant drug fluoxetine held up by pandemic
4 April 2020 - An ongoing shortage of New Zealand's most common antidepressant during the COVID-19 lockdown has one psychiatrist urging patients to consult a doctor before switching medication.
The drug fluoxetine, also known as Prozac, has been in limited supply since late February when Arrow-Fluoxetine tablets were moved to monthly dispensing instead of three months.
The capsules of the same drug were reduced to monthly dispensing in November last year.
